Interaction Between The Protective Effects Of Cannabidiol And Palmitoylethanolamide In Experimental Model Of Multiple Sclerosis In C57bl6 Mice

By | July 5th, 2016|

Immunoactive effects of cannabinoids- considerations for the therapeutic use of cannabinoid receptor agonists and antagonists

By | July 5th, 2016|

Histone Modifications Are Associated with Delta (9)-tetrahydrocannabinol-Mediated Alterations in Antigen-Specific T Cell Responses

By | July 5th, 2016|

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

By | July 5th, 2016|

CB2 cannabinoid receptors as an emerging target for demyelinating diseases- from neuroimmune interactions to cell replacement strategies

By | July 5th, 2016|

Cannabinoids and the immune system

By | July 5th, 2016|

Cannabinoids and the immune system- Potential for the treatment of inflammatory diseases

By | July 5th, 2016|

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

By | July 5th, 2016|

Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties

By | July 5th, 2016|

Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis

By | July 5th, 2016|